Fifth Third Bancorp’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,627
Closed -$299K 2801
2021
Q2
$299K Buy
1,627
+151
+10% +$27.8K ﹤0.01% 855
2021
Q1
$226K Sell
1,476
-102
-6% -$15.6K ﹤0.01% 909
2020
Q4
$247K Buy
1,578
+353
+29% +$55.3K ﹤0.01% 857
2020
Q3
$140K Buy
1,225
+469
+62% +$53.6K ﹤0.01% 1005
2020
Q2
$85K Sell
756
-257
-25% -$28.9K ﹤0.01% 1146
2020
Q1
$91K Buy
1,013
+145
+17% +$13K ﹤0.01% 1066
2019
Q4
$94K Buy
868
+230
+36% +$24.9K ﹤0.01% 1190
2019
Q3
$62K Sell
638
-375
-37% -$36.4K ﹤0.01% 1282
2019
Q2
$133K Sell
1,013
-94
-8% -$12.3K ﹤0.01% 1038
2019
Q1
$150K Sell
1,107
-665
-38% -$90.1K ﹤0.01% 945
2018
Q4
$173K Sell
1,772
-226
-11% -$22.1K ﹤0.01% 894
2018
Q3
$278K Sell
1,998
-11,096
-85% -$1.54M ﹤0.01% 803
2018
Q2
$1.63M Sell
13,094
-24,248
-65% -$3.01M 0.01% 413
2018
Q1
$4.16M Sell
37,342
-2,443
-6% -$272K 0.03% 295
2017
Q4
$4.76M Sell
39,785
-23,541
-37% -$2.82M 0.03% 287
2017
Q3
$8.88M Sell
63,326
-3,254
-5% -$457K 0.06% 226
2017
Q2
$8.1M Sell
66,580
-1,913
-3% -$233K 0.06% 231
2017
Q1
$8.3M Sell
68,493
-2,316
-3% -$281K 0.06% 227
2016
Q4
$8.66M Sell
70,809
-14,929
-17% -$1.83M 0.07% 223
2016
Q3
$10.5M Buy
85,738
+1,689
+2% +$207K 0.09% 199
2016
Q2
$9.81M Buy
84,049
+1,745
+2% +$204K 0.08% 204
2016
Q1
$11.5M Sell
82,304
-22,172
-21% -$3.09M 0.1% 194
2015
Q4
$19.9M Buy
104,476
+4,806
+5% +$917K 0.18% 138
2015
Q3
$15.6M Buy
99,670
+29,427
+42% +$4.6M 0.14% 158
2015
Q2
$12.7M Buy
70,243
+69,172
+6,459% +$12.5M 0.11% 184
2015
Q1
$186K Buy
1,071
+149
+16% +$25.9K ﹤0.01% 1013
2014
Q4
$171K Buy
922
+50
+6% +$9.27K ﹤0.01% 995
2014
Q3
$145K Sell
872
-232
-21% -$38.6K ﹤0.01% 1050
2014
Q2
$173K Sell
1,104
-28
-2% -$4.39K ﹤0.01% 1001
2014
Q1
$172K Sell
1,132
-1,992
-64% -$303K ﹤0.01% 973
2013
Q4
$415K Buy
3,124
+2,501
+401% +$332K ﹤0.01% 760
2013
Q3
$72K Sell
623
-7
-1% -$809 ﹤0.01% 1151
2013
Q2
$58K Buy
+630
New +$58K ﹤0.01% 1247